Effects of oral treatment with chondroitin sulfate and glucosamine in an experimental model of metacarpophalangeal osteoarthritis in horses.

Author: AgresteFernanda Rodrigues, BaccarinRaquel Yvonne Arantes, FülberJoice, MarsigliaMarília Ferrari, SeidelSarah Raphaela Torquato, SoteloEric Danilo Pauls, YamadaAna Lucia Miluzzi, da SilvaLuis Claudio Lopes Correia, do Prado VendruscoloCynthia

Paper Details 
Original Abstract of the Article :
Combined chondroitin sulfate (CS) and glucosamine (GlcN) has been widely used in oral formulations to prevent and treat osteoarthritis. CS is effective for controlling pain in osteoarthritic patients, whereas GlcN can stimulate glycosaminoglycan synthesis, thus reducing extracellular matrix degradat...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9178899/

データ提供:米国国立医学図書館(NLM)

Chondroitin Sulfate and Glucosamine: Effects on Osteoarthritis in Horses

Osteoarthritis (OA), a degenerative joint disease, affects not only humans but also our equine friends. This study explores the potential benefits of oral treatment with chondroitin sulfate (CS) and glucosamine (GlcN) in managing OA in horses. The researchers used an experimental model of metacarpophalangeal OA in horses to investigate the effects of CS and GlcN on the progression of the disease. They aimed to determine whether this combination could effectively treat or modulate OA in this animal model.

Investigating the Effects of CS and GlcN on Osteoarthritis in Horses

The study found that oral treatment with CS and GlcN had a positive effect on the progression of OA in horses. The researchers observed improvements in physical, ultrasonographic, and radiographic examinations, as well as in synovial fluid biomarkers. These findings suggest that CS and GlcN may help manage OA symptoms and potentially slow down disease progression in horses.

Understanding Osteoarthritis and Potential Treatment Options

This study contributes to our understanding of OA in horses and the potential therapeutic benefits of CS and GlcN. The findings encourage further research to validate the effectiveness of this treatment approach and determine its long-term impact on OA management in horses. By exploring various treatment options, we can strive to improve the quality of life for our equine companions and help them navigate the challenges of OA.

Dr. Camel's Conclusion

Just like a camel's strong legs carry it across the desert, healthy joints are vital for the well-being of horses. This study explores the potential of CS and GlcN in managing OA in horses, highlighting the importance of finding effective treatments to support their mobility and quality of life. By embracing research and exploring new approaches, we can strive to ensure that our equine companions experience a comfortable and fulfilling life.

Date :
  1. Date Completed 2022-06-13
  2. Date Revised 2022-07-16
Further Info :

Pubmed ID

35681208

DOI: Digital Object Identifier

PMC9178899

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.